TerminatedNot Applicable

VISIODOL: Validation of the VISIODOL® Scale

Stopped: low recruits

France37 participantsStarted 2019-06-18

Plain-language summary

The aim of this study is to validate the VISIODOL® scale for screening of pain in people with visual impairment.

Who can participate

Age range18 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Healthy volunteers * Subjects aged over 18 / under 60 * Male or female * Subjects fasting from coffee, tea, Coca-Cola and others stimulants * Sufficient understanding and cooperation to comply with the study requirements * Agreed to provide written consent * Affiliated to the social security * Subjects with visual impairment (congenital or acquired) * Subjects with no visual impairment (healthy group) Exclusion Criteria: * Subjects under 18 years old * Administrative and legal criteria (tutorship, curatorship, without social security, in exclusion period of another study)

What they're measuring

Validation of the VISIODOL® scale in screening of pain in people with visual impairment using the correlation coefficient between the intensities measured with the Numerical Scale (NS) and the VISIODOL® scale obtained by using thermal tests.

Timeframe: Day 0 + 2 hours

Trial details

NCT IDNCT03968991

SponsorUniversity Hospital, Clermont-Ferrand

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-12-28

View on ClinicalTrials.gov More Visual Deficiency trials